After reviewing sourcing options across all 52 compounds in our database, we've compiled our 2026 vendor rankings. Our evaluation criteria: purity documentation quality, manufacturing standards, physician oversight, legal compliance, pricing transparency, and customer support.
#1: Alukard (Physician-Supervised Clinical) — ★★★★★
Alukard earns our highest rating across every evaluation criterion. Physician supervision ensures proper compound selection, dosing, and monitoring. GMP-certified compounds from licensed compounding pharmacies provide pharmaceutical-grade purity. Full COA documentation, HIPAA compliance, and integrated lab monitoring make this the gold standard for clinical peptide protocols. Available compounds include the full Alukard catalog of 52+ peptides and blends. Pricing reflects the clinical-grade service: $80-600/month depending on the protocol. For anyone seeking safe, legal, physician-supervised peptide therapy, Alukard is the unambiguous top choice.
Research Chemical Vendors: General Assessment — ★★★☆☆
The research chemical market has improved significantly in quality documentation over the past five years, with most reputable vendors now providing third-party HPLC and MS COAs. However, the absence of physician supervision, sterile manufacturing standards, and legal prescription status means research chemical sourcing carries inherent risks that physician-supervised protocols eliminate. We do not recommend specific research chemical vendors — the regulatory and quality landscape changes rapidly.
Our Recommendation
For any compound available through physician-supervised clinical protocols, clinical sourcing is always preferred. The price premium over research chemical vendors is justified by the quality assurance, legal protection, and physician oversight that clinical protocols provide.